# US 2024/0197953 A1 · Devices and methods for endoscopic plurality strip delivery

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197953 A1
- Document ID: US20240197953A1
- Status: Published application
- Kind: A1
- Application number: 18/530,530
- Filed: 2023-12-06
- Published: 2024-06-20
- Earliest claimed: 2022-12-08
- Assignees: Boston Scientific Scimed, Inc.
- Applicants: Boston Scientific Scimed, Inc.
- Inventors: Lauren S. LYDECKER; Megan CHROBAK; Eric GREENE; Paul SMITH
- Web page: https://patentgrep.com/patent/US20240197953A1

## CPC

- A61B 17/0057: {Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect (sutures A61B17/04; closing rectum or urethra near body surface A61F2/0009)}
- A61L 24/08: Polysaccharides {(A61L24/043 takes precedence)}
- A61B 17/00491: {Surgical glue applicators}
- A61B 17/085: {with adhesive layer}
- A61B 2017/00004: {(bio)absorbable, (bio)resorbable or resorptive}
- A61B 2017/00269: {endoscopic mucosal resection EMR}
- A61B 2017/0034: {adapted to be inserted through a working channel of an endoscope}
- A61B 2017/00522: {Sprayers}
- A61B 2017/00557: {inflatable (A61B2017/22051 takes precedence)}
- A61B 2017/0061: {Implements located only on one side of the opening}
- A61B 2017/00641: {for closing fistulae, e.g. anorectal fistulae}
- A61B 2017/0065: {the implement being an adhesive}
- A61B 2017/00676: {promotion of self-sealing of the puncture}
- A61B 2017/00818: {Treatment of the gastro-intestinal system}
- A61B 2017/00884: {enhancing wound closure}
- A61B 2017/00893: {pharmaceutically effective}
- A61B 2017/00898: {expandable upon contact with fluid}
- A61B 2017/00942: {hydrophilic}
- A61L 2400/04: Materials for stopping bleeding
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

Devices, kits, and methods of delivering a plurality of strips to a tissue defect site to promote covering and/or closure of the tissue defect are described. The kit may include a first medical device configured to push the plurality of strips housed therein through a distal opening and a second medical device defining a working channel for insertion of the first medical device. Methods may include introducing a distal portion of a medical device housing a plurality of strips that include a biocompatible material into a gastrointestinal tract, positioning the distal portion of the device proximate a target site of a tissue wall of the gastrointestinal tract that includes a defect, and applying the plurality of strips to the target site by pushing the plurality of strips out of a distal opening of the device.

## Claims

### Claim 1

A method of treating a subject, the method comprising:
introducing a distal portion of a medical device into a gastrointestinal tract of the subject, wherein the distal portion houses a plurality of strips comprising a biocompatible material;
positioning the distal portion of the device proximate a target site of a tissue wall of the gastrointestinal tract that includes a defect; and
applying the plurality of strips to the target site by pushing the plurality of strips out of a distal opening of the device, wherein the plurality of strips at least partially fill the defect or form a layer over the defect.

### Claim 2 (depends on 1)

The method of claim 1, wherein the biocompatible material comprises chitosan, cellulose, poly(2-hydroxyethyl methacrylate), polystyrene, collagen, gelatin, fibrin, polyethylene glycol (PEG), hyaluronic acid, a block copolymer, or a combination thereof.

### Claim 3 (depends on 2)

The method of claim 2, wherein the biocompatible material comprises, thiolated chitosan, chitosan crosslinked with tripolyphosphate, or carboxymethylcellulose chitosan crosslinked with PEGamine.

### Claim 4 (depends on 1)

The method of claim 1, wherein the biocompatible material is bioresorbable.

### Claim 5 (depends on 1)

The method of claim 1, further comprising applying a therapeutic agent to the target site after applying the plurality of strips to the target site.

### Claim 6 (depends on 5)

The method of claim 5, wherein the therapeutic agent is a hemostatic agent.

### Claim 7 (depends on 5)

The method of claim 5, wherein applying the therapeutic agent comprises spraying the therapeutic agent onto the target site.

### Claim 8 (depends on 1)

The method of claim 1, wherein pushing the plurality of strips out of the distal opening of the device includes advancing a shaft of the device distally to push the plurality strips with a distal end of the shaft.

### Claim 9 (depends on 8)

The method of claim 8, wherein the distal end of the shaft has a cross-sectional dimension larger than a cross-sectional dimension of the shaft, such that the distal end of the shaft contacts and slides along walls of a lumen as the shaft moves along the lumen.

### Claim 10 (depends on 1)

The method of claim 1, wherein each strip of the plurality of strips has a length ranging from about 5 mm to about 40 mm, a width ranging from about 1.5 mm to about 5 mm, or a thickness ranging from about 1 μm to about 100 μm.

### Claim 11 (depends on 1)

The method of claim 1, further comprising applying a biocompatible liquid or a balloon to the plurality of strips after applying the plurality of strips to the target site.

### Claim 12 (depends on 1)

The method of claim 1, wherein the plurality of strips change from a planar configuration when housed within the device to a curled configuration when applied to the target site.

### Claim 13 (depends on 1)

The method of claim 1, wherein the plurality of strips includes at least one strip having a variable thickness along a length of the at least one strip.

### Claim 14

A method of treating a subject, the method comprising:
introducing a distal portion of a medical device into a gastrointestinal tract of the subject, wherein the distal portion of the device defines a lumen that houses a shaft and a chamber proximate a distal end of the device, wherein the chamber houses a plurality of strips comprising a biocompatible material;
positioning the distal portion of the device proximate a target site of a tissue wall that includes a defect;
advancing the shaft distally to push the plurality of strips out of a distal opening of the device and onto the target site; and
applying a biocompatible liquid, a therapeutic agent, or a balloon to the target site after applying the plurality of strips.

### Claim 15 (depends on 14)

The method of claim 14, wherein the biocompatible material comprises chitosan, cellulose, poly(2-hydroxyethyl methacrylate), polystyrene, collagen, gelatin, fibrin, polyethylene glycol (PEG), hyaluronic acid, a block copolymer, or a combination thereof.

### Claim 16 (depends on 14)

The method of claim 14, wherein the biocompatible material is bioresorbable, a hemostatic material, or both.

### Claim 17 (depends on 16)

The method of claim 16, wherein the method includes applying a therapeutic agent to the target site after applying the plurality of strips, the therapeutic agent being a hemostatic agent.

### Claim 18

A method of treating a subject, the method comprising:
introducing a distal portion of a medical device into a gastrointestinal tract of the subject, wherein the distal portion of the device includes a chamber that houses a plurality of strips comprising chitosan or derivative thereof;
positioning the distal portion of the device proximate a target site of a tissue wall of the gastrointestinal tract that includes defect; and
applying the plurality of strips to the target site by pushing the plurality of strips out of a distal opening of the device;
wherein each strip of the plurality of strips has a variable thickness along a length of the strip, and the plurality of strips change from a planar configuration when housed within the device to a curled configuration when applied to the target site.

### Claim 19 (depends on 18)

The method of claim 18, further comprising applying a biocompatible liquid, a therapeutic agent, or a balloon to the target site after applying the plurality of strips to the target site.

### Claim 20 (depends on 19)

The method of claim 19, wherein the method includes spraying water or an aqueous solution having an acidic pH onto the target site after applying the plurality of strips to the target site.
